Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer
Clinical trial NCT00400803 · COMPLETED
Trial details
- NCT number
- NCT00400803
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2010-05-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.